Publication
Treatment of systemic sclerosis with tocilizumab.
| dc.contributor.author | Neves, M | |
| dc.contributor.author | Oliveira, S | |
| dc.contributor.author | Amaral, M | |
| dc.contributor.author | Alves, JD | |
| dc.date.accessioned | 2016-11-14T16:56:46Z | |
| dc.date.available | 2016-11-14T16:56:46Z | |
| dc.date.issued | 2015 | |
| dc.identifier.citation | Rheumatology (Oxford). 2015 Feb;54(2):371-2 | pt_PT |
| dc.identifier.doi | 10.1093/rheumatology/keu435 | pt_PT |
| dc.identifier.issn | 1462-0332 | |
| dc.identifier.uri | http://hdl.handle.net/10400.10/1743 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Oxford University Press | pt_PT |
| dc.relation.publisherversion | http://rheumatology.oxfordjournals.org/content/54/2/371.full.pdf+html | pt_PT |
| dc.subject | Systemic scleroderma | pt_PT |
| dc.subject | Chronic disease | pt_PT |
| dc.subject | Escleroderma sistémico | pt_PT |
| dc.subject | Doença crónica | pt_PT |
| dc.subject | Tocilizumab | pt_PT |
| dc.title | Treatment of systemic sclerosis with tocilizumab. | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.conferencePlace | Oxford | pt_PT |
| oaire.citation.endPage | 372 | pt_PT |
| oaire.citation.startPage | 371 | pt_PT |
| oaire.citation.title | Rheumatology (Oxford) | pt_PT |
| oaire.citation.volume | 54 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |